Comparison of high-frequency and ultrahigh-frequency probes in chronic inflammatory demyelinating polyneuropathy.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 26 03 2019
accepted: 20 05 2019
revised: 17 05 2019
pubmed: 9 6 2019
medline: 29 1 2020
entrez: 9 6 2019
Statut: ppublish

Résumé

High-frequency ultrasound (HFUS 18-20 MHz) performed on patients with chronic inflammatory demyelinating polyneuropathy (CIDP) shows a focal enlargement, particularly in the proximal segments of upper-arm motor nerves. Ultrahigh frequency ultrasound (UHFUS 30-70 MHz), having a higher spatial resolution, enables a better characterization of nerve structures. The aim of this study was to compare the two ultrasound probes in the evaluation of motor nerve characteristics in CIDP patients. Eleven patients with definite or probable CIDP underwent an ultrasound evaluation of median and ulnar nerves, bilaterally. Nerve and fascicle cross-sectional area (CSA), vascularization, and echogenicity were assessed. Nerve and fascicle CSA were increased in the proximal segments, especially in the median nerve, in 9/11 patients and in 10/11 patients at the HFUS and UHFUS evaluations, respectively. A statistically significant difference between CSA values obtained with the two probes was found only for fascicle values. UHFUS allowed for a more precise estimation of fascicle size and number than the HFUS. We were able to identify nerve vascularization in 4/11 patients at UHFUS only. UHFUS gives more detailed information on the changes in the internal nerve structure in CIDP patients. In particular, it permits to better characterize fascicle size and morphology, and to have a precise estimation of their number. Its frequency range also allows to evaluate nerve vascularization. Ultrasound evaluation could become an adjunctive diagnostic tool for CIDP. Further studies are needed to validate the examined parameters as biomarkers for the evaluation and follow-up of CIDP patients.

Identifiants

pubmed: 31175432
doi: 10.1007/s00415-019-09392-z
pii: 10.1007/s00415-019-09392-z
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2277-2285

Références

Anat Rec. 1963 Feb;145:149-55
pubmed: 14020058
J Peripher Nerv Syst. 2010 Mar;15(1):1-9
pubmed: 20433600
Eur J Neurol. 2010 Mar;17(3):356-63
pubmed: 20456730
Brain. 1945 Dec;68:243-99
pubmed: 20982793
Eur J Neurol. 2013 Oct;20(10):1342-51
pubmed: 23701599
Clin Neurophysiol. 2014 Jan;125(1):154-9
pubmed: 23880223
Clin Neurophysiol. 2014 Jan;125(1):160-5
pubmed: 24099922
Clin Neurophysiol. 2014 Sep;125(9):1893-9
pubmed: 24560630
J Neuroimaging. 2015 Mar-Apr;25(2):207-216
pubmed: 24593005
Ultrasound Med Biol. 2014 Jun;40(6):1138-45
pubmed: 24613217
Muscle Nerve. 2014 Dec;50(6):976-83
pubmed: 24634226
Neurology. 2015 Feb 24;84(8):803-9
pubmed: 25632087
J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):973-85
pubmed: 25677463
J Neurol Sci. 2015 Oct 15;357(1-2):198-203
pubmed: 26227829
J Neuroimaging. 2015 Nov-Dec;25(6):931-9
pubmed: 26242571
Clin Neurophysiol. 2016 Jul;127(7):2618-24
pubmed: 27291881
Muscle Nerve. 2017 Feb;55(2):285-289
pubmed: 27463360
J Neurol. 2017 Feb;264(2):243-253
pubmed: 27878436
Neurology. 2017 Jan 10;88(2):143-151
pubmed: 27927940
Muscle Nerve. 2017 Sep;56(3):463-471
pubmed: 28006854
Muscle Nerve. 2017 Oct;56(4):819-822
pubmed: 28214293
Clin Neurophysiol. 2017 Dec;128(12):2521-2526
pubmed: 28958781
Clin Neurophysiol. 2018 Jan;129(1):155-167
pubmed: 29190522
Neurotherapeutics. 2018 Apr;15(2):439-451
pubmed: 29435815
J Neurol. 2019 Feb;266(2):468-475
pubmed: 30554264
Muscle Nerve. 1996 Feb;19(2):163-9
pubmed: 8559164

Auteurs

Angela Puma (A)

Peripheral Nervous System, Muscle and ALS Department, CHU Nice, Université Côte D'Azur, Nice, France. puma.ar@chu-nice.fr.
UMR7370 CNRS, LP2M, Labex ICST, Faculty of Medicine, Université Nice Côte d'Azur, Nice, France. puma.ar@chu-nice.fr.

N Azulay (N)

Ultrasound Department, CHU Nice, Université Côte d'Azur, Nice, France.

N Grecu (N)

Peripheral Nervous System, Muscle and ALS Department, CHU Nice, Université Côte D'Azur, Nice, France.

C Suply (C)

Peripheral Nervous System, Muscle and ALS Department, CHU Nice, Université Côte D'Azur, Nice, France.

E Panicucci (E)

Peripheral Nervous System, Muscle and ALS Department, CHU Nice, Université Côte D'Azur, Nice, France.

C Cambieri (C)

Peripheral Nervous System, Muscle and ALS Department, CHU Nice, Université Côte D'Azur, Nice, France.
Department of Human Neuroscience, Centre of Rare Neuromuscular Diseases, Sapienza University of Rome, Rome, Italy.

L Villa (L)

Peripheral Nervous System, Muscle and ALS Department, CHU Nice, Université Côte D'Azur, Nice, France.
Pathology Department, CHU Nice, Université Côte d'Azur, Nice, France.

C Raffaelli (C)

Ultrasound Department, CHU Nice, Université Côte d'Azur, Nice, France.

S Sacconi (S)

Peripheral Nervous System, Muscle and ALS Department, CHU Nice, Université Côte D'Azur, Nice, France.
Institute for Research on Cancer and Aging of Nice (IRCAN), INSERM U1081, CNRS UMR 7284, Faculty of Medicine, Université Côte d'Azur (UCA), Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH